Voyager Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -114.01 M

Voyager Therapeutics, Inc. Free Cash Flow is USD -114.01 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -1,484.79% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Voyager Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 8.23 M, a -88.82% change year over year.
  • Voyager Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 73.67 M, a 7,881.37% change year over year.
  • Voyager Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 923.00 K, a -100.92% change year over year.
  • Voyager Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -100.18 M, a -11.67% change year over year.
Key Data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities